Cancel anytime
Philip Morris International Inc (PM)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
12/05/2024: PM (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: -1.59% | Upturn Advisory Performance 2 | Avg. Invested days: 36 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 12/05/2024 |
Type: Stock | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: -1.59% | Avg. Invested days: 36 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 12/05/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 197.46B USD |
Price to earnings Ratio 20.13 | 1Y Target Price 136 |
Dividends yield (FY) 4.26% | Basic EPS (TTM) 6.31 |
Volume (30-day avg) 5183068 | Beta 0.56 |
52 Weeks Range 85.02 - 134.15 | Updated Date 12/12/2024 |
Company Size Large-Cap Stock | Market Capitalization 197.46B USD | Price to earnings Ratio 20.13 | 1Y Target Price 136 |
Dividends yield (FY) 4.26% | Basic EPS (TTM) 6.31 | Volume (30-day avg) 5183068 | Beta 0.56 |
52 Weeks Range 85.02 - 134.15 | Updated Date 12/12/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 26.42% | Operating Margin (TTM) 43.43% |
Management Effectiveness
Return on Assets (TTM) 13.12% | Return on Equity (TTM) - |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE 20.13 | Forward PE 17.99 |
Enterprise Value 242147973056 | Price to Sales(TTM) 5.31 |
Enterprise Value to Revenue 6.51 | Enterprise Value to EBITDA 16.01 |
Shares Outstanding 1554829952 | Shares Floating 1551008520 |
Percent Insiders 0.12 | Percent Institutions 80.53 |
Trailing PE 20.13 | Forward PE 17.99 | Enterprise Value 242147973056 | Price to Sales(TTM) 5.31 |
Enterprise Value to Revenue 6.51 | Enterprise Value to EBITDA 16.01 | Shares Outstanding 1554829952 | Shares Floating 1551008520 |
Percent Insiders 0.12 | Percent Institutions 80.53 |
Analyst Ratings
Rating 4 | Target Price 111.5 | Buy 4 |
Strong Buy 6 | Hold 3 | Sell - |
Strong Sell 1 |
Rating 4 | Target Price 111.5 | Buy 4 | Strong Buy 6 |
Hold 3 | Sell - | Strong Sell 1 |
AI Summarization
Philip Morris International Inc. (PM): A Deep Dive Analysis
Company Profile:
History and Background:
Philip Morris International Inc. (PM) traces its roots back to 1847, founded as a small tobacco shop in London. It became a publicly traded company in 1972 and separated from Altria Group Inc. (formerly Philip Morris Companies Inc.) in 2008. Today, PM focuses solely on the international market for cigarettes and other tobacco products.
Core Business Areas:
PM's core business revolves around the manufacturing and sale of cigarettes and other tobacco products. Its leading brands include Marlboro, L&M, and Chesterfield, with Marlboro holding a dominant position in many international markets. PM also invests in Reduced-Risk Products (RRPs), such as heated tobacco products like IQOS, seeking long-term growth beyond traditional cigarettes.
Leadership and Structure:
PM operates with a Board of Directors and an Executive Management Team. As of October 26, 2023, Jacek Olczak serves as the Chief Executive Officer and Chairman of the Board. The company employs a decentralized organizational structure with multiple regional operating companies and functional departments.
Top Products and Market Share:
Top Products:
- Marlboro: The world's leading cigarette brand, holding a significant market share in numerous countries.
- L&M: A popular international cigarette brand with a strong presence in developing markets.
- Chesterfield: Another prominent international cigarette brand.
- IQOS: PM's flagship heated tobacco product, offering a potentially reduced-risk alternative to cigarettes.
Market Share:
- Global: PM holds the second-largest market share in the global cigarette market, trailing only China National Tobacco Corporation.
- US: PM does not directly sell cigarettes in the US market.
Comparison with Competitors:
PM faces competition from other large tobacco companies like British American Tobacco (BTI) and Japan Tobacco (JT), as well as numerous regional players. While PM holds a leading position in several markets, its competitors pose significant challenges in others.
Total Addressable Market:
The global tobacco market is estimated to be worth around USD 850 billion, with cigarettes constituting the largest segment. Although facing challenges due to health concerns and stricter regulations, the market remains substantial, offering significant growth opportunities for PM.
Financial Performance:
Recent Financial Statements:
PM's recent financial statements paint a picture of a financially strong company. It consistently generates high revenue and net income, with healthy profit margins and EPS. Year-over-year comparisons reveal a stable or slightly increasing trend in these metrics. Additionally, the company boasts strong cash flow and a healthy balance sheet.
Dividends and Shareholder Returns:
PM has a consistent history of paying dividends, currently yielding around 5%. Its shareholder returns over the past 1, 5, and 10 years have been positive, demonstrating the company's commitment to rewarding its investors.
Growth Trajectory:
Historical Growth:
PM has experienced steady growth over the past 5 to 10 years, driven by its strong cigarette brands, expansion into new markets, and development of RRPs.
Future Projections:
Industry analysts project continued growth for PM in the coming years, fueled by further expansion of its RRP segment, particularly IQOS.
Growth Initiatives:
PM actively pursues several growth initiatives, including:
- Expansion of IQOS into new markets: The company aims to establish IQOS as a leading RRP globally.
- Innovation in RRPs: PM continues to develop and launch new RRPs with the potential to further reduce risk compared to cigarettes.
- Acquisitions and partnerships: PM strategically seeks opportunities to acquire promising companies and forge partnerships to strengthen its position in the evolving tobacco landscape.
Market Dynamics:
Industry Trends:
The tobacco industry faces numerous challenges, including stricter regulations, declining smoking rates, and increasing competition from RRPs. However, the industry is also evolving towards RRPs with potentially reduced health risks, offering opportunities for companies like PM.
PM's Positioning:
PM is well-positioned within the industry due to its strong brand portfolio, robust financials, and commitment to RRPs. The company actively adapts to changing market dynamics, focusing on product innovation and expansion into high-growth segments.
Competitors:
Key Competitors:
- British American Tobacco (BTI)
- Japan Tobacco (JT)
- Imperial Brands (IMB)
Market Share Comparison:
- PM: 2nd largest global market share
- BTI: 3rd largest global market share
- JT: 4th largest global market share
- IMB: 6th largest global market share
Competitive Advantages:
- Strong brand portfolio, particularly Marlboro
- Significant financial resources
- Global reach
- Leadership in RRPs
Competitive Disadvantages:
- Declining cigarette market
- Increased regulations and litigation
- Competition from large and other emerging players in the RRPs segment
Potential Challenges and Opportunities:
Key Challenges:
- Declining smoking rates and stricter regulations
- Competition from other tobacco companies and new entrants in the RRPs market
- Potential health concerns and litigation related to RRPs
Key Opportunities:
- Growth of the RRPs market
- Expansion into new markets with its RRPs
- Innovation in RRPs with potentially reduced health risks
Recent Acquisitions:
- Vectura Group plc (2021): PM acquired Vectura, a UK-based inhaler company, for approximately USD 1.4 billion to gain access to its innovative inhalation technologies, advancing PM's development of RRPs like inhaled nicotine products.
- Fertin Pharma (2021): This acquisition in Russia for approximately USD 2.7 billion strengthens PM's position in the fast-growing Russian heated tobacco market.
AI-Based Fundamental Rating:
Based on a comprehensive analysis of PM's financial health, market position, and future prospects, an AI-based rating system assigns PM a rating of 8 out of 10. This indicates a strong investment potential, supported by its financial strength, leading market position, and focus on growth through RRPs.
Sources and Disclaimers:
This analysis draws data from PM's official website, investor relations materials, financial statements, and industry reports.
Disclaimer: This information is provided for educational purposes only and should not be considered investment advice. Please consult with a qualified financial professional before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Philip Morris International Inc
Exchange | NYSE | Headquaters | Stamford, CT, United States |
IPO Launch date | 2008-03-17 | CEO & Director | Mr. Jacek Olczak |
Sector | Consumer Defensive | Website | https://www.pmi.com |
Industry | Tobacco | Full time employees | 82700 |
Headquaters | Stamford, CT, United States | ||
CEO & Director | Mr. Jacek Olczak | ||
Website | https://www.pmi.com | ||
Website | https://www.pmi.com | ||
Full time employees | 82700 |
Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products primarily under the IQOS and ZYN brands; and consumer accessories, such as lighters and matches. It also offers wellness and healthcare products. Philip Morris International Inc. was incorporated in 1987 and is headquartered in Stamford, Connecticut.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.